+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
RNA Based Therapeutics and Vaccines Market Report 2022-2032 - Product Thumbnail Image

RNA Based Therapeutics and Vaccines Market Report 2022-2032

  • Report
  • October 2022
  • 213 Pages
  • Global
From
From
From
From
From
From
Generic Pharmaceuticals Global Market Report 2024 - Product Thumbnail Image

Generic Pharmaceuticals Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
Neuroprotection Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Neuroprotection Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 194 Pages
  • Global
From
Neurology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2023-2033

  • Report
  • January 2023
  • 262 Pages
  • Global
From
Psoriasis Global Market Report 2024 - Product Thumbnail Image

Psoriasis Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Loading Indicator